Tramadol has a triple action all of which are relevant in treating psychic suffering, especially suffering from the feelings of psychic “pain” that can arise from social loss. As it is short acting, has a wide therapeutic range as a weak mu-receptor agonist, has a relatively low risk for inducing neurochemical tolerance, and comparatively low risk for abuse, tramadol needs to be further evaluated for the treatment of depression.